Danaher Corporation (DHR)

130.39
1.09 0.84
NYSE
Prev Close 129.30
Open 128.76
Day Low/High 128.14 / 130.77
52 Wk Low/High 94.59 / 127.53
Volume 2.14M
Exchange NYSE
Shares Outstanding 715.93B
Market Cap 91.48B
Div & Yield N.A. (N.A)
GE's Wake Up Call

GE's Wake Up Call

Victory at General Electric will likely have to wait.

General Electric Trades Higher Despite Downbeat Profit Forecast for 2019 'Reset'

General Electric Trades Higher Despite Downbeat Profit Forecast for 2019 'Reset'

General Electric issued fresh 2019 earnings guidance Thursday that missed analysts' forecast, sending shares in the troubled industrial giant sharply lower in pre-market trading.

General Electric Shares Pop After Citigroup Sees 'Relatively Few' 2019 Surprises

General Electric Shares Pop After Citigroup Sees 'Relatively Few' 2019 Surprises

General Electric shares jumped higher Monday after analyst at Citigroup said the company's recent warning on industrial free cash flow might mean its 2019 outlook is a bit clearer, even as the bank trimmed its price target on the stock following last week's sharp sell-off.

Weekly Roundup

With China reducing its GDP forecast and Europe's central bank growing cautious, markets turned lower this week.

Danaher Announces Quarterly Dividend

Danaher Announces Quarterly Dividend

WASHINGTON, March 8, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.

Trimming Shares of Danaher

We still view the stock as a core holding.

What to Expect from GE's Health Care Conference on Thursday

What to Expect from GE's Health Care Conference on Thursday

One of General Electric's biggest liabilities will be outlined on Thursday.

General Electric Extends Declines After Culp Pressed on Industrial Cash Flows

General Electric Extends Declines After Culp Pressed on Industrial Cash Flows

General Electric shares extended declines Wednesday, taking shares to a fresh one-month low, after CEO Larry Culp warned that free cash flow from the conglomerate's industrial division is likely to remain negative this year.

General Electric Shares Slump After CEO Culp Warns on Industrial Free Cash Flow

General Electric Shares Slump After CEO Culp Warns on Industrial Free Cash Flow

General Electric Larry Culp said Tuesday that free cash flow from the conglomerate's industrial division is likely to remain negative this year but insisted the troubled group would accelerate its ongoing restructuring plan.

Trimming Danaher at the Open

Danaher is a terrific multi-year story in the portfolio and represents a perfect example of why you can count on strong leadership teams over the long run.

Last Week's Portfolio Changes

We raised our price targets on Danaher and Palo Alto Networks last week.

Weekly Roundup

Markets end volatile week little changed in spite of failed North Korea summit, and congressional testimony from Powell, Lighthizer and Cohen.

Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

WASHINGTON, March 1, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.

Markets Trending Slightly Lower on Wednesday

The health insurance stocks are taking a hit today, but we're not sellers on Wednesday's news.

General Electric CEO Larry Culp Pledges Debt Reduction, Eventual Dividend Boost

General Electric CEO Larry Culp Pledges Debt Reduction, Eventual Dividend Boost

General Electric shares traded higher Wednesday after CEO Larry Culp told investors he was focused on reducing the conglomerate's debt load and boosting its dividend to a level "in line with our peers."

General Electric Biopharma Sale Helps Debt Reduction, Hurts Earnings - JPM Tusa

General Electric Biopharma Sale Helps Debt Reduction, Hurts Earnings - JPM Tusa

General Electric's move to sell the biopharma portion of its healthcare business to Danaher likely gives the company and extra $3 billion it can use to reduce its balance sheet, but will also cut into overall earnings in an already weakened company, according to one of Wall Street's top analysts.

Danaher Announces Pricing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

Danaher Announces Pricing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

WASHINGTON, Feb. 26, 2019 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced concurrent offerings of 11,000,000 shares of common stock at a price to the public of $123.

Trimming PayPal for a Nice Gain

We've been slowly scaling out of this name, selling shares on its gradual climb higher because of valuation reasons.

Win, With or Without China: Cramer's 'Mad Money' Recap (Monday 2/25/19)

Win, With or Without China: Cramer's 'Mad Money' Recap (Monday 2/25/19)

Jim Cramer asks whether there aren't enough good things happening that we can sustain an advance without a China deal.

Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock

Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock

WASHINGTON, Feb. 25, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has commenced concurrent offerings of $1.

Dow Closes Modestly Higher After Trump Extends China Tariff Deadline

Dow Closes Modestly Higher After Trump Extends China Tariff Deadline

The Dow Jones Industrial Average rose modestly Monday after Donald Trump said he will delay increasing tariffs on China-made goods.

Jim Cramer: How to Win Now, With or Without China

Jim Cramer: How to Win Now, With or Without China

If we can advance without China then who the heck knows where we can go with it.

How to Trade General Electric After $23.4 Billion Asset Sale

How to Trade General Electric After $23.4 Billion Asset Sale

Both Danaher and General Electric stocks are flying higher after the latter agreed to sell its biopharma unit to the latter for $23.4 billion.

Markets Higher as Tariff Deadline Extended, DHR Price Target Update

A trade deal with China would be meaningful for any company that does a solid amount of business in the region, and perhaps more so the stocks tied to global economic growth.

Is General Electric Still a Decent Value Play?

Is General Electric Still a Decent Value Play?

Just because the stock is still down substantially from its all-time highs doesn't mean that it is still 'cheap'.

Video: Jim's Daily Rundown for Monday

Jim breaks down the huge Danaher-GE deal, discusses what to make of CVS after last week's earnings report, talks about what a trade deal could mean for the broader market, and more!

Why Jim Cramer's a Fan of GE Selling Its Biopharma Business to Danaher

Why Jim Cramer's a Fan of GE Selling Its Biopharma Business to Danaher

Here's why Jim Cramer was pleased that General Electric sold its biopharma business to Danaher and what it means for Larry Culp's leadership.

General Electric Sells Biopharma Unit for $21.4 Billion as Culp Unwind Continues

General Electric Sells Biopharma Unit for $21.4 Billion as Culp Unwind Continues

General Electric agreesd to sell the biopharma portion of its life sciences business to Danaher, the firm that GE CEO Larry Culp ran for around 13 years, for $21.4 billion in cash.

Jim Cramer's Thoughts on General Electric's Biopharma Sale and Kraft Heinz

Jim Cramer's Thoughts on General Electric's Biopharma Sale and Kraft Heinz

Jim Cramer has an acquisition idea for Berkshire Hathaway and his reaction to GE's sale of its biopharma sale.

Larry Culp Showed Up at the Right Time for General Electric

Larry Culp Showed Up at the Right Time for General Electric

The question for us though becomes is this, or when is, the right time for investors to create some value for themselves?

TheStreet Quant Rating: B (Buy)